BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 26880218)

  • 1. Epidermal growth factor induces p38 MAPK-dependent G0/G1-to-S transition in prostate cancer cells upon androgen deprivation conditions.
    Rodríguez-Berriguete G; Torrealba N; Fraile B; Paniagua R; Royuela M
    Growth Factors; 2016 Feb; 34(1-2):5-10. PubMed ID: 26880218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Signaling Network Controlling Androgenic Repression of c-Fos Protein in Prostate Adenocarcinoma Cells.
    Shankar E; Song K; Corum SL; Bane KL; Wang H; Kao HY; Danielpour D
    J Biol Chem; 2016 Mar; 291(11):5512-5526. PubMed ID: 26786102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest.
    Kokontis JM; Hay N; Liao S
    Mol Endocrinol; 1998 Jul; 12(7):941-53. PubMed ID: 9658399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of amino acid transporter LAT1 in cancer cells suppresses G0/G1-S transition by downregulating cyclin D1 via p38 MAPK activation.
    Zhou X; Ohgaki R; Jin C; Xu M; Okanishi H; Endou H; Kanai Y
    J Pharmacol Sci; 2024 Mar; 154(3):182-191. PubMed ID: 38395519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p38 MAPK regulates G1-S transition in hypoxic cardiac fibroblasts.
    Pillai MS; Sapna S; Shivakumar K
    Int J Biochem Cell Biol; 2011 Jun; 43(6):919-27. PubMed ID: 21420505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lycopene differentially induces quiescence and apoptosis in androgen-responsive and -independent prostate cancer cell lines.
    Ivanov NI; Cowell SP; Brown P; Rennie PS; Guns ES; Cox ME
    Clin Nutr; 2007 Apr; 26(2):252-63. PubMed ID: 17337101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of NF-κB-related proteins and their modulation during TNF-α-provoked apoptosis in prostate cancer cells.
    Rodríguez-Berriguete G; Fraile B; Paniagua R; Aller P; Royuela M
    Prostate; 2012 Jan; 72(1):40-50. PubMed ID: 21520161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3,3'-Diindolylmethane induces a G(1) arrest in human prostate cancer cells irrespective of androgen receptor and p53 status.
    Vivar OI; Lin CL; Firestone GL; Bjeldanes LF
    Biochem Pharmacol; 2009 Sep; 78(5):469-76. PubMed ID: 19433067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synchronized prostate cancer cells for studying androgen regulated events in cell cycle progression from G1 into S phase.
    Cifuentes E; Croxen R; Menon M; Barrack ER; Reddy GP
    J Cell Physiol; 2003 Jun; 195(3):337-45. PubMed ID: 12704643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells.
    Recchia AG; Musti AM; Lanzino M; Panno ML; Turano E; Zumpano R; Belfiore A; Andò S; Maggiolini M
    Int J Biochem Cell Biol; 2009 Mar; 41(3):603-14. PubMed ID: 18692155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of lysine-specific demethylase 1 promotes androgen-independent transition of human prostate cancer LNCaP cells through activation of the AR signaling pathway and suppression of the p53 signaling pathway.
    Li X; Li T; Chen D; Zhang P; Song Y; Zhu H; Xiao Y; Xing Y
    Oncol Rep; 2016 Jan; 35(1):584-92. PubMed ID: 26534764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Icilin induces G1 arrest through activating JNK and p38 kinase in a TRPM8-independent manner.
    Kim SH; Kim SY; Park EJ; Kim J; Park HH; So I; Kim SJ; Jeon JH
    Biochem Biophys Res Commun; 2011 Mar; 406(1):30-5. PubMed ID: 21284938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inositol hexaphosphate inhibits growth and induces G1 arrest and apoptotic death of androgen-dependent human prostate carcinoma LNCaP cells.
    Agarwal C; Dhanalakshmi S; Singh RP; Agarwal R
    Neoplasia; 2004; 6(5):646-59. PubMed ID: 15548374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines.
    Putz T; Culig Z; Eder IE; Nessler-Menardi C; Bartsch G; Grunicke H; Uberall F; Klocker H
    Cancer Res; 1999 Jan; 59(1):227-33. PubMed ID: 9892211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profiling of androgen-dependent and -independent LNCaP cells: EGF versus androgen signalling.
    Oosterhoff JK; Grootegoed JA; Blok LJ
    Endocr Relat Cancer; 2005 Mar; 12(1):135-48. PubMed ID: 15788645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protoapigenone, a novel flavonoid, induces apoptosis in human prostate cancer cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase 1/2.
    Chang HL; Wu YC; Su JH; Yeh YT; Yuan SS
    J Pharmacol Exp Ther; 2008 Jun; 325(3):841-9. PubMed ID: 18337475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obatoclax induces G1/G0-phase arrest via p38/p21(waf1/Cip1) signaling pathway in human esophageal cancer cells.
    Zhong D; Gu C; Shi L; Xun T; Li X; Liu S; Yu L
    J Cell Biochem; 2014 Sep; 115(9):1624-35. PubMed ID: 24788582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of calcium-independent phospholipase A2 activates p38 MAPK signaling pathways during cytostasis in prostate cancer cells.
    Sun B; Zhang X; Yonz C; Cummings BS
    Biochem Pharmacol; 2010 Jun; 79(12):1727-35. PubMed ID: 20171194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposite effects of JNK and p38 MAPK signaling pathways on furazolidone-stimulated S phase cell cycle arrest of human hepatoblastoma cell line.
    Sun Y; Tang S; Jin X; Zhang C; Zhao W; Xiao X
    Mutat Res; 2013 Jul; 755(1):24-9. PubMed ID: 23660333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity.
    Siu SW; Lau KW; Tam PC; Shiu SY
    Prostate; 2002 Jul; 52(2):106-22. PubMed ID: 12111702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.